Increased Resolvin E1 Production by Peripheral Blood Mononuclear Cells in Periodontitis Patients: Pilot Study

Area of Science:

• Oral immunology
• Inflammation resolution biology

Background:

• Periodontitis is a chronic inflammatory disease affecting the gums and supporting structures.
• Lipopolysaccharide (LPS) from Porphyromonas gingivalis (Pg) is a key trigger in periodontitis pathogenesis.
• Resolvin E1 (RvE1) is a pro-resolving mediator with potential anti-inflammatory roles.

Purpose of the Study:

• To quantify Resolvin E1 production by peripheral blood mononuclear cells (PBMC) in individuals with and without periodontitis.
• To investigate the effect of Porphyromonas gingivalis lipopolysaccharide (Pg LPS) on RvE1 production.
• To explore RvE1 as a potential biomarker for inflammation resolution in periodontitis.

Main Methods:

• Recruitment of 20 participants (10 periodontitis patients, 10 healthy controls), aged 30-50, matched for sex.
• Isolation and in vitro stimulation of peripheral blood mononuclear cells (PBMC) with Pg LPS for 24 hours.
• Quantification of Resolvin E1 levels in cell culture supernatants using enzyme-linked immunosorbent assay (ELISA).

Main Results:

• LPS stimulation significantly increased RvE1 production in both periodontitis and healthy groups compared to baseline (p<0.001).
• Patients with periodontitis exhibited significantly higher RvE1 levels upon LPS stimulation compared to healthy controls (p=0.0019).
• These findings suggest an enhanced inflammatory resolution response in periodontitis patients.

Conclusions:

• Resolvin E1 production is upregulated by Pg LPS stimulation.
• Elevated RvE1 levels in periodontitis patients may indicate a compensatory mechanism for inflammation resolution.
• RvE1 warrants further clinical investigation as a potential biomarker for assessing the resolution of inflammation in periodontitis.